Genomic Epidemiology of SARS-CoV-2 in Ukraine from May 2022 to March 2024 Reveals Omicron Variant Dynamics
Viruses · 2025
DOI: 10.3390/v17071000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Anna Iaruchyk und 8 weiteren Autor:innen. Beteiligte Einrichtung: World Health Organization Country Office, 01021 Kyiv, Ukraine. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Ministry of Foreign Affairs of the Netherlands, WHO Ukraine Emergency Appeal.
Abstract (Originalsprache)
In Ukraine, SARS-CoV-2 detection and national genomic surveillance have been complicated by full-scale war, limited resources, and varying levels of public health infrastructure impacted across the country. Following the Spring of 2022, only a paucity of data have been reported describing the prevalence and variant dynamics of SARS-CoV-2 in the country. Comparative whole genome analysis has overtaken diagnostics as the new gold standard for detecting and tracing emerging variants while showing utility to rapidly inform diagnostics, vaccine strategies, and health policy. Herein, we provide an updated report characterizing the dynamics and prevalence of SARS-CoV-2 in Ukraine from 1 May 2022 to 31 March 2024. The present study extends previous reports for disease incidence Waves 1–4 in Ukraine with the addition herein of Waves 5, 6, and 7, occurring from August to November 2022 (Wave 5), February to May 2023 (Wave 6), and October 2023 to January 2024 (Wave 7). During the study period, the national Case Fatality Rate (CFR) fluctuated between 0.46% and 1.74%, indicating a consistent yet modest rate when compared to the global average. The epidemiological dynamics of Variants of Concern (VOCs) in Ukraine reflected global patterns over this period, punctuated by the rise of the BA.5 lineage and its subsequent replacement by the Omicron subvariants XBB and JN.1. Our analysis of variant dispersal patterns revealed multiple potential spatiotemporal introductions into Ukraine from Europe, Asia, and North America. Our results highlight the importance of ongoing genomic surveillance to monitor variant dynamics and support global efforts to control and mitigate COVID-19 disease risks as new variants arise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- World Health Organization Country Office, 01021 Kyiv, Ukraine.
- Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ 86011, USA.
- Public Health Center of the Ministry of Health of Ukraine, 04071 Kyiv, Ukraine.
ORCID-Profile: Anna Iaruchyk, Jarno Habicht
Förderung
- World Health Organization
- Ministry of Foreign Affairs of the Netherlands
- WHO Ukraine Emergency Appeal
- project “WHO Health Emergency Response in Ukraine”
- Government of the Federal Republic of Germany
Zitieren
APA
Iaruchyk, A., Farlow, J., Skrypnyk, A., Matchyshyn, S., Kovalchuk, A., Demchyshyna, I., Rosada, M., Aregay, A. K., & Habicht, J. (2025). Genomic Epidemiology of SARS-CoV-2 in Ukraine from May 2022 to March 2024 Reveals Omicron Variant Dynamics. Viruses. https://doi.org/10.3390/v17071000
Vancouver
Iaruchyk A, Farlow J, Skrypnyk A, Matchyshyn S, Kovalchuk A, Demchyshyna I, et al. Genomic Epidemiology of SARS-CoV-2 in Ukraine from May 2022 to March 2024 Reveals Omicron Variant Dynamics. Viruses. 2025. doi:10.3390/v17071000
BibTeX
@article{Iaruchyk2025,
author = {Iaruchyk, Anna and Farlow, Jason and Skrypnyk, Artem and Matchyshyn, Serhii and Kovalchuk, Alina and Demchyshyna, Iryna and Rosada, Mykhailo and Aregay, Aron Kassahun and Habicht, Jarno},
title = {Genomic Epidemiology of SARS-CoV-2 in Ukraine from May 2022 to March 2024 Reveals Omicron Variant Dynamics},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17071000}
}
EUVIMED